Cigna Group (NYSE:CI) Receives Hold (C+) Rating from Weiss Ratings

Key Points

• Cigna Group has received a "hold (C+)" rating from Weiss Ratings, indicating a cautious outlook from the ratings agency.
• Despite the hold rating, a mix of analysts have rated Cigna Group with two "Strong Buy" and fourteen "Buy" ratings, leading to a consensus rating of "Moderate Buy" with a target price of $372.69.
• The company's stock closed at $306.57 with a recent earnings report showing a net margin of 1.92% and a year-over-year revenue increase of 11%, highlighting its financial stability.

Cigna Group (NYSE:CI - Get Free Report)'s stock had its "hold (c+)" rating reiterated by Weiss Ratings in a research note issued to investors on Wednesday,Weiss Ratings reports.

Several other research analysts also recently commented on the stock. TD Cowen raised shares of Cigna Group to a "strong-buy" rating in a report on Monday, June 23rd. Wells Fargo & Company lifted their price objective on shares of Cigna Group from $340.00 to $354.00 and gave the stock an "equal weight" rating in a report on Tuesday. Guggenheim reaffirmed a "buy" rating and set a $350.00 price objective (down from $388.00) on shares of Cigna Group in a report on Monday, August 4th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $365.00 price objective on shares of Cigna Group in a report on Tuesday, August 26th. Finally, Barclays lifted their price objective on shares of Cigna Group from $354.00 to $383.00 and gave the stock an "overweight" rating in a report on Thursday, September 4th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Cigna Group presently has a consensus rating of "Moderate Buy" and a consensus price target of $372.69.

Cigna Group Stock Performance

Cigna Group stock traded down $0.57 during mid-day trading on Wednesday, reaching $306.57. The company's stock had a trading volume of 1,164,571 shares, compared to its average volume of 1,542,765. Cigna Group has a 12-month low of $256.89 and a 12-month high of $358.88. The company has a market capitalization of $81.83 billion, a P/E ratio of 16.73, a PEG ratio of 0.90 and a beta of 0.45. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The firm's fifty day moving average price is $293.11 and its two-hundred day moving average price is $309.52.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating the consensus estimate of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. During the same period last year, the firm earned $6.72 EPS. The business's quarterly revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Sell-side analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Insider Activity

In related news, insider Brian C. Evanko sold 5,368 shares of the business's stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the sale, the insider owned 51,182 shares of the company's stock, valued at $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Nicole S. Jones sold 28,526 shares of the business's stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares in the company, valued at $7,694,400. The trade was a 52.66% decrease in their position. The disclosure for this sale can be found here. 0.70% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in CI. Modern Wealth Management LLC lifted its position in Cigna Group by 91.3% during the first quarter. Modern Wealth Management LLC now owns 3,130 shares of the health services provider's stock valued at $1,030,000 after purchasing an additional 1,494 shares during the period. Janney Montgomery Scott LLC increased its holdings in Cigna Group by 3.9% during the second quarter. Janney Montgomery Scott LLC now owns 35,943 shares of the health services provider's stock valued at $11,882,000 after buying an additional 1,357 shares during the last quarter. Acadian Asset Management LLC increased its holdings in Cigna Group by 277.5% during the first quarter. Acadian Asset Management LLC now owns 8,274 shares of the health services provider's stock valued at $2,718,000 after buying an additional 6,082 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in Cigna Group during the first quarter valued at approximately $431,000. Finally, Integrity Alliance LLC. purchased a new stake in Cigna Group during the first quarter valued at approximately $617,000. Institutional investors own 86.99% of the company's stock.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.